SCHEMBL4848823

SCHEMBL4848823

CC(C)(C)[Si](OCc1cccc(CCCCCC(=O)O)c1)(c1ccccc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.50
RXFP1 Q9HBX9 1/20 0.50
TBXAS1 P24557 7/20 0.45
CYSLTR2 Q9NS75 2/20 0.44
CYSLTR1 Q9Y271 2/20 0.44
PPARG P37231 1/20 0.43
PPARA Q07869 1/20 0.43
HDAC3 O15379 1/20 0.42
MAPK1 P28482 1/20 0.42
ADRA1A P35348 1/20 0.42
HDAC4 P56524 1/20 0.42
SLC6A3 Q01959 1/20 0.42
HDAC1 Q13547 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4841595 0.90 HDAC6 (0.41) MAPTRXFP1PPARGPPARAHDAC1
SCHEMBL4848468 0.87 CYP4F2 (0.41) PPARGPPARALTB4R
SCHEMBL25456702 0.82 CYSLTR2 (0.50) MAPTRXFP1TBXAS1CYSLTR2CYSLTR1
SCHEMBL8024035 0.81 CYP4F2 (0.46) PPARGPPARA
SCHEMBL9566211 0.80 FFAR1 (0.40)
SCHEMBL8024443 0.79 MRGPRX4 (0.38) MAPTCYSLTR1SMN1; SMN2
SCHEMBL31528916 0.79 TBXA2R (0.43) MAPTRXFP1TBXAS1PPARAHDAC3
SCHEMBL30887240 0.79 TBXA2R (0.43) MAPTRXFP1TBXAS1PPARAHDAC3
SCHEMBL31528895 0.79 TBXA2R (0.43) MAPTRXFP1TBXAS1PPARAHDAC3
SCHEMBL25355046 0.79 TBXA2R (0.43) MAPTRXFP1TBXAS1PPARAHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE40558-E1 Therapeutic uses of di-aryl acid derivatives SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2008-10-28 US disclosed
US-6635655-B1 Agonists or antagonists of peroxisome proliferator-activated receptors AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-10-21 US disclosed
EP-1177187-A1 DI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS Aventis Pharma Deutschland GmbH (DE) 2002-02-06 EP disclosed
WO-2000064888-A1 DI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-11-02 WO disclosed